Caribou Biosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.99

+0.09 (+4.74%)

As of Apr 1, 10:08 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +306.0% upside

Low Target $6.79

Average Target $8.08

High Target $13.52

Current Price $1.99

Current
$1.99

Target
$8.08

$6.79 $8.08 avg $13.52

Scenario Analysis

Bear Case

$6.79

241.2%

Low target

Base Case

$8.08

+306.0%

Avg target

Bull Case

$13.52

+579.4%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$3.54

-43.7% from high

52-Week Low

$0.66

+201.5% from low

Target vs 52W High

$8.08

+128.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%